Recombinant Human RHBDD2 Protein，GST

RHBDD2, also known as RING finger and HD domain containing E3 ubiquitin-protein ligase 2, has emerged as a pivotal protein in cellular signaling and protein degradation pathways. This E3 ligase plays a crucial role in the ubiquitin-proteasome system, which regulates various cellular processes such as cell cycle progression, apoptosis, and responses to stress. Research has shown that RHBDD2 is involved in endoplasmic reticulum-associated degradation (ERAD), a mechanism that eliminates misfolded proteins from the endoplasmic reticulum, thereby ensuring cellular homeostasis and preventing the accumulation of potentially toxic aggregates. Dysregulation of RHBDD2 expression has been linked to various diseases, including cancer and neurodegenerative disorders, highlighting its potential as a therapeutic target. Recent studies have focused on characterizing the structural and functional properties of RHBDD2 to better understand its role in disease pathways. The generation of recombinant RHBDD2 proteins allows researchers to investigate its enzymatic activity and interaction with substrates in vitro, contributing to the elucidation of its biological functions. Understanding the molecular mechanisms underlying RHBDD2's activity could pave the way for novel strategies to manipulate its function for therapeutic purposes. Furthermore, as the field of targeted protein degradation continues to advance, RHBDD2 stands out as a candidate for the development of small-molecule modulators that can adjust its ligase activity, thereby offering new avenues for experimental and clinical applications in disease management.